PL368730A1 - Preformulacja do tabletkowania naturalnych mieszanin sprzężonych estrogenów - Google Patents

Preformulacja do tabletkowania naturalnych mieszanin sprzężonych estrogenów

Info

Publication number
PL368730A1
PL368730A1 PL02368730A PL36873002A PL368730A1 PL 368730 A1 PL368730 A1 PL 368730A1 PL 02368730 A PL02368730 A PL 02368730A PL 36873002 A PL36873002 A PL 36873002A PL 368730 A1 PL368730 A1 PL 368730A1
Authority
PL
Poland
Prior art keywords
tabletting
formulation
conjugated estrogens
natural mixtures
mixtures
Prior art date
Application number
PL02368730A
Other languages
English (en)
Other versions
PL205544B1 (pl
Inventor
Bernd Thumbeck
Ingo Bonnacker
Martina Lerch
Original Assignee
Solvay Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals Gmbh filed Critical Solvay Pharmaceuticals Gmbh
Publication of PL368730A1 publication Critical patent/PL368730A1/pl
Publication of PL205544B1 publication Critical patent/PL205544B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL368730A 2001-12-14 2002-12-12 Preformulacja farmaceutyczna do tabletkowania zawierająca sprzężone końskie estrogeny oraz sposób jej wytwarzania PL205544B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01129840 2001-12-14

Publications (2)

Publication Number Publication Date
PL368730A1 true PL368730A1 (pl) 2005-04-04
PL205544B1 PL205544B1 (pl) 2010-04-30

Family

ID=8179550

Family Applications (1)

Application Number Title Priority Date Filing Date
PL368730A PL205544B1 (pl) 2001-12-14 2002-12-12 Preformulacja farmaceutyczna do tabletkowania zawierająca sprzężone końskie estrogeny oraz sposób jej wytwarzania

Country Status (13)

Country Link
US (2) US8273728B2 (pl)
EP (1) EP1458363B1 (pl)
JP (1) JP4695838B2 (pl)
CN (2) CN1298313C (pl)
AR (1) AR037642A1 (pl)
AU (1) AU2002358682B2 (pl)
BR (1) BR0214954A (pl)
CA (1) CA2470209A1 (pl)
ES (1) ES2403218T3 (pl)
MX (1) MXPA04005767A (pl)
PL (1) PL205544B1 (pl)
TW (1) TWI332400B (pl)
WO (1) WO2003051337A1 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9586335B2 (en) * 2010-01-27 2017-03-07 Sd3, Llc Blade guard with dust collection
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens
US8349819B2 (en) 2002-10-09 2013-01-08 Dr. Reddy's Laboratories New York, Inc. Steroid extraction process from urine sources
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090232897A1 (en) * 2008-03-14 2009-09-17 Bijayananda Sahoo Pharmaceutical compositions comprising conjugated estrogens
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
CA2768452A1 (en) * 2009-07-16 2011-01-20 Avantor Performance Materials, Inc. Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2013083674A1 (de) * 2011-12-08 2013-06-13 Hexal Ag Neue pharmazeutische statin-zusammensetzung
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
WO2021162906A1 (en) * 2020-02-11 2021-08-19 Sheh Fung Screws Co., Ltd Fastener having improved wobble control, fastening system including the same, and method of forming the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
US4154820A (en) 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
DE3535536A1 (de) 1985-10-04 1987-04-09 Lentia Gmbh Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
EP0322020A1 (en) * 1987-12-22 1989-06-28 Akzo N.V. Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
AU722084B2 (en) 1996-08-30 2000-07-20 Abbott Products Gmbh Process to obtain oestrogens from mare's urine
JP4285773B2 (ja) 1996-08-30 2009-06-24 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング 牝馬の尿からエストロゲンを取得する方法
US6200289B1 (en) 1998-04-10 2001-03-13 Milestone Scientific, Inc. Pressure/force computer controlled drug delivery system and the like
JP2000156938A (ja) 1998-11-19 2000-06-06 Hokuto Denko Kk 電池の充放電試験装置
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens

Also Published As

Publication number Publication date
US20050009800A1 (en) 2005-01-13
CN1607944A (zh) 2005-04-20
CN100502839C (zh) 2009-06-24
HK1104220A1 (zh) 2008-01-11
TWI332400B (en) 2010-11-01
ES2403218T3 (es) 2013-05-16
US8273728B2 (en) 2012-09-25
CN1298313C (zh) 2007-02-07
WO2003051337A1 (de) 2003-06-26
AR037642A1 (es) 2004-11-17
AU2002358682B2 (en) 2009-03-26
TW200408400A (en) 2004-06-01
AU2002358682A1 (en) 2003-06-30
BR0214954A (pt) 2004-12-14
US20120237666A1 (en) 2012-09-20
EP1458363B1 (de) 2013-01-16
CN1977862A (zh) 2007-06-13
PL205544B1 (pl) 2010-04-30
CA2470209A1 (en) 2003-06-26
HK1075007A1 (en) 2005-12-02
MXPA04005767A (es) 2004-09-10
US8329679B2 (en) 2012-12-11
EP1458363A1 (de) 2004-09-22
JP4695838B2 (ja) 2011-06-08
JP2005516923A (ja) 2005-06-09

Similar Documents

Publication Publication Date Title
PL368730A1 (pl) Preformulacja do tabletkowania naturalnych mieszanin sprzężonych estrogenów
IL150230A0 (en) Fulvestrant formulation
GB0023983D0 (en) Therapeutic compounds
GB0008710D0 (en) Therapeutic compounds
GB0016681D0 (en) Therapeutic compounds
EP1398040A4 (en) MEDICAL COMPOSITION
GB0020691D0 (en) Pharmaceutical combination
GB0028583D0 (en) Therapeutic compounds
GB0012291D0 (en) Pharmaceutical combination
GB0122731D0 (en) Anti-inflammatory agent
GB0012293D0 (en) Pharmaceutical combination
GB0021487D0 (en) Pharmaceutical
GB0016426D0 (en) Pharmaceutical combination
GB0017666D0 (en) Pharmaceutical combination
AU2001287111A1 (en) Human vomeronasal receptor-3
GB0022521D0 (en) Medicinal compounds
GB0007628D0 (en) Medicinal compounds
GB0105741D0 (en) Medicinal compounds
GB0127024D0 (en) Medicinal compounds
GB0126997D0 (en) Medicinal Compounds
GB0122201D0 (en) Medicinal compounds
GB0105740D0 (en) Medicinal compounds
GB0020769D0 (en) Pharmaceutical combination
GB0016427D0 (en) Pharmaceutical combination
GB0016428D0 (en) Pharmaceutical combination